Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention

Introduction: There is some controversy over the efficacy of statins for the prevention of contrastinduced nephropathy (CIN). There have also been reports on varying efficacies of different statins. Hence, in this study the efficacy of atorvastatin and rosuvastatin for the prevention of CIN was asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Firouzi, Ata, Kazem Moussavi, Ali, Mohebbi, Ahmad, Alemzadeh-Ansari, Mohammad Javad, Kiani, Reza, Sanati, Hamid Reza, Mohebbi, Bahram, Shakerian, Farshad, Zahedmehr, Ali, Ansari-Ramandi, Mohammad Mostafa, Oni Heris, Saeed, Ghaleshi, Bahar, Ghorbani, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203872/
https://www.ncbi.nlm.nih.gov/pubmed/30386535
http://dx.doi.org/10.15171/jcvtr.2018.24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203872/
https://www.ncbi.nlm.nih.gov/pubmed/30386535
http://dx.doi.org/10.15171/jcvtr.2018.24

Ejemplares similares